Vector Development
Adeno-associated virus gene vectors may treat hemophilia B
Published in Blood Weekly, January 13th, 2005
According to a review from the United States, "adeno-associated viral (AAV) vector is attracting significant interest for use in gene therapy for genetic diseases, because of its unique and advantageous characteristics, compared to other currently available viral vectors. Eight natural serotypes of AAV have been identified, of which AAV serotype 2 is the one best characterized and most widely used in current gene delivery studies."
"The application of AAV serotype 2 in hemophilia B gene therapy is a promising development in gene therapy for genetic diseases such as hemophilia," wrote H.J....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-01-13)
More Articles from Blood Weekly
- Genetic Testing
Rapid prenatal diagnosis by QF-PCR detects major numerical chromosome disorders - Stem Cell Research
SC expressing homing receptors expanded from cryopreserved/unselected cord blood - Stem Cell Transplantation
IL-8 may play important role during engraftment after hematopoietic SCT - Stem Cell Transplantation
Routine high resolution HLA-A/B/C typing does not improve HSCT outcome - Tissue Engineering
Novel tissue scaffolds developed for craniofacial and joint defects - Acute Myelogenous Leukemia
Farnesyl transferase inhibitor can help patients at high-risk for AML - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
